Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 1/2016

01-02-2016 | Original Article

Systematic analysis to identify a key role of CDK1 in mediating gene interaction networks in cervical cancer development

Authors: Y. Luo, Y. Wu, Y. Peng, X. Liu, J. Bie, S. Li

Published in: Irish Journal of Medical Science (1971 -) | Issue 1/2016

Login to get access

Abstract

Objective

This study aims to identify corresponding differentially expressed genes in cervical cancer by comparing gene expression profiles between normal and cervical cancer samples.

Method

To identify differentially expressed genes in cervical cancer, two groups of Affymetrix microarray data available online were analyzed. One group consisted of 43 carcinomatous cervical epithelial cell samples, and the other was composed of 17 healthy cervical epithelial cell samples, both from the Amerindian. R packages—GO.db, KEGG.db and KEGGREST were used to detect GO categories and KEGG pathways with significant overrepresentation in differentially expressed genes comparing with the whole genome. Cytoscape was utilized to construct biological networks.

Results

By comparing gene expression profile of normal and cervical cancer samples, 122 differentially expressed genes were identified including 46 up-regulated genes and 76 down-regulated genes. Using the identified differentially expressed genes, a large and a small biological network was constructed. In addition, 402 GO biological processes and 9 KEGG pathways were over-represented. Top significant biological processes included cell cycle and cell proliferation. Moreover, top significant KEGG pathways were oocyte meiosis, cell cycle and progesterone-mediated oocyte maturation. Most importantly, CDK1 frequently appeared in these processes and pathways, which indicated its significant role in the progression of cervical cancer.

Conclusion

CDK1 plays a comprehensive role in mediating genetic networks implicated in the progression of cervical cancer. Novel therapeutics targeting CDK1 or its related pathways might help improve prognosis of advanced stage cervical cancer.
Appendix
Available only for authorised users
Literature
2.
go back to reference Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10(8):789–799PubMedCrossRef Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10(8):789–799PubMedCrossRef
3.
go back to reference Thomas A et al (2013) Expression profiling of cervical cancers in Indian women at different stages to identify gene signatures during progression of the disease. Cancer Med 2(6):836–848PubMedPubMedCentralCrossRef Thomas A et al (2013) Expression profiling of cervical cancers in Indian women at different stages to identify gene signatures during progression of the disease. Cancer Med 2(6):836–848PubMedPubMedCentralCrossRef
4.
go back to reference Cheng Q et al (2002) Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma. Int J Cancer 98(3):419–426PubMedCrossRef Cheng Q et al (2002) Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma. Int J Cancer 98(3):419–426PubMedCrossRef
5.
go back to reference Wong YF et al (2006) Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. Int J Cancer 118(10):2461–2469PubMedCrossRef Wong YF et al (2006) Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. Int J Cancer 118(10):2461–2469PubMedCrossRef
6.
go back to reference Guardado-Estrada M et al (2012) The Amerindian mtDNA haplogroup B2 enhances the risk of HPV for cervical cancer: de-regulation of mitochondrial genes may be involved. J Hum Genet 57(4):269–276PubMedCrossRef Guardado-Estrada M et al (2012) The Amerindian mtDNA haplogroup B2 enhances the risk of HPV for cervical cancer: de-regulation of mitochondrial genes may be involved. J Hum Genet 57(4):269–276PubMedCrossRef
8.
go back to reference Tavazoie S et al (1999) Systematic determination of genetic network architecture. Nat Genet 22(3):281–285PubMedCrossRef Tavazoie S et al (1999) Systematic determination of genetic network architecture. Nat Genet 22(3):281–285PubMedCrossRef
9.
go back to reference Keshava Prasad TS et al (2009) Human protein reference database–2009 update. Nucleic Acids Res 37(Database issue):D767–D772 Keshava Prasad TS et al (2009) Human protein reference database–2009 update. Nucleic Acids Res 37(Database issue):D767–D772
10.
go back to reference Chatr-Aryamontri A et al (2013) The BioGRID interaction database: 2013 update. Nucleic Acids Res 41(Database issue):D816–D823 Chatr-Aryamontri A et al (2013) The BioGRID interaction database: 2013 update. Nucleic Acids Res 41(Database issue):D816–D823
11.
go back to reference McDowall MD, Scott MS, Barton GJ (2009) PIPs: human protein-protein interaction prediction database. Nucleic Acids Res 37(Database issue):D651–D656 McDowall MD, Scott MS, Barton GJ (2009) PIPs: human protein-protein interaction prediction database. Nucleic Acids Res 37(Database issue):D651–D656
13.
go back to reference Santin AD et al (2005) Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virology 331(2):269–291PubMedCrossRef Santin AD et al (2005) Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virology 331(2):269–291PubMedCrossRef
15.
go back to reference Seo MJ et al (2005) New approaches to pathogenic gene function discovery with human squamous cell cervical carcinoma by gene ontology. Gynecol Oncol 96(3):621–629PubMedCrossRef Seo MJ et al (2005) New approaches to pathogenic gene function discovery with human squamous cell cervical carcinoma by gene ontology. Gynecol Oncol 96(3):621–629PubMedCrossRef
16.
go back to reference Deryugina EI, Quigley JP (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25(1):9–34PubMedCrossRef Deryugina EI, Quigley JP (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25(1):9–34PubMedCrossRef
17.
go back to reference Zhai Y et al (2005) Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion. Cancer Res 65(15):6543–6550PubMedCrossRef Zhai Y et al (2005) Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion. Cancer Res 65(15):6543–6550PubMedCrossRef
18.
go back to reference Sheu BC et al (2003) Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer. Cancer Res 63(19):6537–6542PubMed Sheu BC et al (2003) Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer. Cancer Res 63(19):6537–6542PubMed
19.
go back to reference Song JY et al (2008) Microarray analysis of normal cervix, carcinoma in situ, and invasive cervical cancer: identification of candidate genes in pathogenesis of invasion in cervical cancer. Int J Gynecol Cancer 18(5):1051–1059PubMedCrossRef Song JY et al (2008) Microarray analysis of normal cervix, carcinoma in situ, and invasive cervical cancer: identification of candidate genes in pathogenesis of invasion in cervical cancer. Int J Gynecol Cancer 18(5):1051–1059PubMedCrossRef
20.
go back to reference Cho H et al (2008) Clinical significance of osteopontin expression in cervical cancer. J Cancer Res Clin Oncol 134(8):909–917PubMedCrossRef Cho H et al (2008) Clinical significance of osteopontin expression in cervical cancer. J Cancer Res Clin Oncol 134(8):909–917PubMedCrossRef
21.
go back to reference Conesa-Zamora P (2013) Role of cell cycle biomarkers in human papillomavirus related uterine lesions. Curr Pharm Des 19(8):1412–1424PubMed Conesa-Zamora P (2013) Role of cell cycle biomarkers in human papillomavirus related uterine lesions. Curr Pharm Des 19(8):1412–1424PubMed
22.
go back to reference Lau E et al (2007) The role of pre-replicative complex (pre-RC) components in oncogenesis. FASEB J 21(14):3786–3794PubMedCrossRef Lau E et al (2007) The role of pre-replicative complex (pre-RC) components in oncogenesis. FASEB J 21(14):3786–3794PubMedCrossRef
24.
go back to reference Yun J et al (1999) p53 negatively regulates cdc2 transcription via the CCAAT-binding NF-Y transcription factor. J Biol Chem 274(42):29677–29682PubMedCrossRef Yun J et al (1999) p53 negatively regulates cdc2 transcription via the CCAAT-binding NF-Y transcription factor. J Biol Chem 274(42):29677–29682PubMedCrossRef
25.
go back to reference Cho NH et al (2006) Elevation of cyclin B1, active cdc2, and HuR in cervical neoplasia with human papillomavirus type 18 infection. Cancer Lett 232(2):170–178PubMedCrossRef Cho NH et al (2006) Elevation of cyclin B1, active cdc2, and HuR in cervical neoplasia with human papillomavirus type 18 infection. Cancer Lett 232(2):170–178PubMedCrossRef
26.
go back to reference Cerciello F et al (2005) G2/M cell cycle checkpoint is functional in cervical cancer patients after initiation of external beam radiotherapy. Int J Radiat Oncol Biol Phys 62(5):1390–1398PubMedCrossRef Cerciello F et al (2005) G2/M cell cycle checkpoint is functional in cervical cancer patients after initiation of external beam radiotherapy. Int J Radiat Oncol Biol Phys 62(5):1390–1398PubMedCrossRef
27.
go back to reference Malumbres M, Barbacid M (2005) Mammalian cyclin-dependent kinases. Trends Biochem Sci 30(11):630–641PubMedCrossRef Malumbres M, Barbacid M (2005) Mammalian cyclin-dependent kinases. Trends Biochem Sci 30(11):630–641PubMedCrossRef
28.
go back to reference Hall M, Peters G (1996) Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 68:67–108PubMedCrossRef Hall M, Peters G (1996) Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 68:67–108PubMedCrossRef
29.
go back to reference Shapiro GI (2006) Cyclin-dependent kinase pathways as targets for cancer treatment. J Clin Oncol 24(11):1770–1783PubMedCrossRef Shapiro GI (2006) Cyclin-dependent kinase pathways as targets for cancer treatment. J Clin Oncol 24(11):1770–1783PubMedCrossRef
30.
go back to reference Zeng Q et al (2012) IPP5, a novel inhibitor of protein phosphatase 1, suppresses tumor growth and progression of cervical carcinoma cells by inducing G2/M arrest. Cancer Genet 205(9):442–452PubMedCrossRef Zeng Q et al (2012) IPP5, a novel inhibitor of protein phosphatase 1, suppresses tumor growth and progression of cervical carcinoma cells by inducing G2/M arrest. Cancer Genet 205(9):442–452PubMedCrossRef
31.
go back to reference Emanuel S et al (2005) The in vitro and in vivo effects of JNJ-7706621: a dual inhibitor of cyclin-dependent kinases and aurora kinases. Cancer Res 65(19):9038–9046PubMedCrossRef Emanuel S et al (2005) The in vitro and in vivo effects of JNJ-7706621: a dual inhibitor of cyclin-dependent kinases and aurora kinases. Cancer Res 65(19):9038–9046PubMedCrossRef
32.
go back to reference Sutherland RL, Musgrove EA (2009) CDK inhibitors as potential breast cancer therapeutics: new evidence for enhanced efficacy in ER + disease. Breast Cancer Res 11(6):112PubMedPubMedCentralCrossRef Sutherland RL, Musgrove EA (2009) CDK inhibitors as potential breast cancer therapeutics: new evidence for enhanced efficacy in ER + disease. Breast Cancer Res 11(6):112PubMedPubMedCentralCrossRef
33.
go back to reference Gao SY et al (2014) Downregulation of Cdk1 and CyclinB1 Expression Contributes to Oridonin-induced Cell Cycle Arrest at G2/M Phase and Growth Inhibition in SGC-7901 Gastric Cancer Cells. Asian Pac J Cancer Prev 15(15):6437–6441PubMedCrossRef Gao SY et al (2014) Downregulation of Cdk1 and CyclinB1 Expression Contributes to Oridonin-induced Cell Cycle Arrest at G2/M Phase and Growth Inhibition in SGC-7901 Gastric Cancer Cells. Asian Pac J Cancer Prev 15(15):6437–6441PubMedCrossRef
Metadata
Title
Systematic analysis to identify a key role of CDK1 in mediating gene interaction networks in cervical cancer development
Authors
Y. Luo
Y. Wu
Y. Peng
X. Liu
J. Bie
S. Li
Publication date
01-02-2016
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 1/2016
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-015-1283-8

Other articles of this Issue 1/2016

Irish Journal of Medical Science (1971 -) 1/2016 Go to the issue